Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Jack Weinstein News

Page 33 - Jack Weinstein News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jack Weinstein. Real-time updates on events, politics, business and more.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir

November 29, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study results Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical
David Schoenfeld Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Eqs Group
Source: finanznachrichten.de

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence

November 24, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Alliance Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities
Michael Miller Raghuram Ram Selvaraju Jack Weinstein Advita Lifescience Gmb Pharma Research Eqs Group
Source: finanznachrichten.de

Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product De

November 24, 2021
RELIEF THERAPEUTICS Holding AG / Key word(s): Alliance24-Nov-2021 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development...
Michael Miller Raghuram Ram Selvaraju Jack Weinstein Advita Lifescience Gmb Pharma Big Data Innovation Lab Platform Pharma Research
Source: pharmiweb.com

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil

November 24, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Regulatory Admission Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied
Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Drug Administration Eqs Group
Source: finanznachrichten.de

Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administrati

November 24, 2021
RELIEF THERAPEUTICS Holding AG / Key word(s): Regulatory Admission24-Nov-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administr...
Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Drug Administration Swiss Exchange
Source: pharmiweb.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner's Emergency Use Authorization Request for ZYESAMI/RLF-100 (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure was Declined by U.S. FDA

November 5, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports U.S. Collaboration Partner's Emergency Use Authorization Request for ZYESAMI/RLF-100 (aviptadil) for Patients
Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Drug Administration Eqs Group
Source: finanznachrichten.de

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner has Announced Favorable New Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19

November 3, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study results Relief Reports U.S. Collaboration Partner has Announced Favorable New Safety Report for Aviptadil in NIH Sponsored ACTIV-3b
Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research Eqs Group
Source: finanznachrichten.de

EQS-Adhoc: Relief Reports U.S. Collaboration Partner has Announced Favorable New Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19

November 3, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study results Relief Reports U.S. Collaboration Partner has Announced Favorable New Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19 03-Nov-2021 / 07:00 CET/CEST Re...
Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research Eqs Group
Source: boersennews.de

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics Takes First Step to Create an ADR Program in the United States by filing a Form F-6 Registration Statement with the U.S. Securities and Exchange Commission

November 3, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Therapeutics Takes First Step to Create an ADR Program in the United States by filing a Form F-6 Registration Statement
United States Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Eqs Group
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science